{"key":"op_177_ES","page":{"url":"https://ua.bookimed.com/clinics/country=spain/procedure=allogenic-bone-marrow-transplantation-from-a-related-donor/","procedure":{"id":177,"slug":"allogenic-bone-marrow-transplantation-from-a-related-donor","name":"Трансплантація кісткового мозку алогенна від спорідненого донора","name_forms":{"plural":{"status":"missing","reason":"not_collected"},"genitive":{"status":"missing","reason":"not_collected"}},"type":"therapy","grammar_number":{"status":"missing","reason":"not_collected"},"parent_id":"oncology","family_attribute":{"status":"missing","reason":"not_collected"}},"country":{"id":34,"iso":"ES","name":"Іспанія"},"currency":"USD","data_date":"2026-09-25"},"pages":{"clinics_url":"https://ua.bookimed.com/clinics/country=spain/procedure=allogenic-bone-marrow-transplantation-from-a-related-donor/","cost_url":"https://ua.bookimed.com/clinics/country=spain/procedure=allogenic-bone-marrow-transplantation-from-a-related-donor/cost/","best_url":{"status":"missing","reason":"template not live"}},"price":{"from":130000,"to":220000,"avg":{"value":252989,"method":"median","source":"offers"},"us":{"from":320000,"to":480000},"uk":{"from":150000,"to":250000},"by_technique":[{"technique":"Myeloablative conditioning followed by related-donor marrow infusion","technique_id":"myeloablative-conditioning","price_from":160000,"currency":"USD","source":"estimate","date":"2026-11-17"},{"technique":"Reduced-intensity conditioning followed by related-donor marrow infusion","technique_id":"reduced-intensity","price_from":140000,"currency":"USD","source":"estimate","date":"2026-11-17"}],"by_city":[{"city":"Памплона","from":130000},{"city":"Мадрид","from":178000},{"city":"Аліканте","from":75000},{"city":"Барселона","from":85000}],"per_unit":{"status":"missing","reason":"not_collected"},"factors":{"status":"missing","reason":"not_collected"},"tiers":{"source":"offers","items":[{"tier":"standard","min":252989,"max":252989,"median":252989,"count":1}]},"comparison":[{"country_iso":"UA","from":38000,"to":55000},{"country_iso":"FR","from":85000,"to":125000},{"country_iso":"GB","from":150000,"to":250000},{"country_iso":"US","from":320000,"to":480000},{"country_iso":"IL","from":95000,"to":135000},{"country_iso":"TR","from":43700,"to":65000},{"country_iso":"MX","from":55000,"to":85000},{"country_iso":"DE","from":130000,"to":180000},{"country_iso":"CA","from":150000,"to":235000},{"country_iso":"AE","from":90000,"to":150000},{"country_iso":"TH","from":95000,"to":135000},{"country_iso":"PL","from":48000,"to":75000},{"country_iso":"KR","from":85000,"to":125000},{"country_iso":"CZ","from":70000,"to":100000},{"country_iso":"AT","from":95000,"to":150000},{"country_iso":"IT","from":75000,"to":120000},{"country_iso":"CN","from":60000,"to":70000},{"country_iso":"AU","from":120000,"to":185000},{"country_iso":"IN","from":25000,"to":28000},{"country_iso":"MY","from":38000,"to":58000},{"country_iso":"VN","from":24000,"to":38000},{"country_iso":"BR","from":85000,"to":120000},{"country_iso":"AZ","from":65000,"to":{"status":"missing","reason":"not_collected"}},{"country_iso":"EG","from":20000,"to":40000}],"base_country":"US","base_is_fallback":false},"savings":{"pct":59,"variant":">=15%"},"package":{"included":["Individual chamber"],"excluded":["Transfer is not included"],"extra_charges":{"status":"missing","reason":"not_collected"}},"clinics":{"count":5,"items":[{"id":278,"name":"Quironsalud Madrid","city":"Madrid","rating":3.8,"reviews_count":6,"accreditations":["World's Best Hospitals 2021 by Newsweek"],"rank":1,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":[{"id":"5d6900aa59436a170a091f8c","price":252989,"nights":35,"included":["Individual chamber"],"excluded":["Transfer is not included"],"other_services":"When a related donor is available, the first priority is to confirm that allogeneic transplantation is truly indicated, assess the current disease status, and establish whether the family donor is sufficiently compatible. I recommend evaluation with Prof. Luis Madero at Hospital Universitario Quirónsalud Madrid, where the case can be reviewed within a dedicated pediatric hemato-oncology pathway. Why Prof. Luis Madero • Head of Pediatric Hemato-Oncology at Hospital Universitario Quirónsalud Madrid. • Head of Pediatric Hemato-Oncology and Hematopoietic Transplantation at Hospital Niño Jesús in Madrid. • Professor of Pediatrics at Universidad Autónoma de Madrid. • Author of more than 200 international scientific publications, with extensive experience in childhood leukemia, lymphoma, bone marrow disorders and hematopoietic transplantation. Why Quirónsalud Madrid The hospital has a dedicated Pediatric Hemato-Oncology Service and can coordinate hematology, pediatrics, intensive care, transfusion medicine, laboratory diagnostics and specialist support within the same hospital. For transplantation, the team evaluates the patient and potential related donor together, including HLA compatibility, infectious screening and organ-function testing before treatment is approved. Evaluation and treatment package • Consultation with Prof. Luis Madero • Review of bone marrow biopsy, pathology, cytogenetics and molecular studies. • Complete blood count, biochemistry and coagulation profile. • HLA typing of the patient and related donor. • Donor medical assessment and infectious-disease screening. • Cardiac, pulmonary, renal and liver assessment. • Bone marrow examination if an updated evaluation is required. • Conditioning chemotherapy. • Collection of hematopoietic stem cells from the related donor. • Allogeneic stem-cell infusion. • Protective inpatient hospitalization during marrow recovery. • Blood-product and anti-infective support. • Prevention and monitoring of graft-versus-host disease. • Early post-transplant follow-up. • Complete pre-transplant patient and donor evaluation • Related-donor allogeneic bone marrow/stem-cell transplantation"}]},{"id":272,"name":"SJD Barcelona Children’s Hospital","city":"Barcelona","rating":4.7,"reviews_count":44,"accreditations":["Bookimed Award: Best pediatric hospital","World's Best Specialized Hospitals 2022 by Newsweek"],"rank":2,"has_procedure":true,"why_ranked":"Reports 90–100% survival for related-donor transplants. Eight dedicated stem cell chambers sit inside Europe’s largest pediatric cancer center; HEPA-filtered rooms lower infection risk, and SEGUIM coordinates long-term follow-up.","bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":78,"name":"Centro Médico Teknon","city":"Barcelona","rating":4.7,"reviews_count":498,"accreditations":["Joint Commission International","European Foundation for Quality Management","THE IMTJ MEDICAL TRAVEL AWARD WINNER IN 2019","Patient choice in Neurology","Patient choice in Neurosurgery","Patient choice for Epilepsy treatment","World's Best Hospitals 2021 by Newsweek"],"rank":3,"has_procedure":true,"why_ranked":"JCI accredited clinic with a leading oncohematologist. Offers comprehensive diagnostics and consultation for bone marrow transplants. 97% client recommendation rate.","bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":6225,"name":"Hospital Ruber Internacional","city":"Madrid","rating":5,"reviews_count":3,"accreditations":["Joint Commission International","International Organization for Standardization"],"rank":4,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":339,"name":"Clinica Universidad de Navarra (Navarra Hospital)","city":"Pamplona","rating":4.7,"reviews_count":7,"accreditations":["Joint Commission International","European Society for Medical Oncology","World's Best Hospitals 2020 by Newsweek","World's Best Hospitals 2021 by Newsweek","World's Best Smart Hospitals 2021 by Newsweek","World's Best Hospitals 2022 by Newsweek","World's Best Smart Hospitals 2023 by Newsweek"],"rank":5,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}}]},"doctors":{"count":4,"languages":{"status":"missing","reason":"not_collected"}},"cities":[{"id":366,"slug":"pamplona","name":"Памплона","clinics_count":1,"price_from":130000,"profile":{"status":"missing","reason":"not_collected"}},{"id":346,"slug":"madrid","name":"Мадрид","clinics_count":1,"price_from":178000,"profile":{"city_type":"Capital and largest city of Spain","access":["Madrid Barajas Airport (MAD), 13 km from Puerta del Sol"],"sources":["https://en.wikipedia.org/wiki/Madrid","https://en.wikipedia.org/wiki/Madrid–Barajas_Airport"],"checked_at":"2026-11-03","status":"ok"}},{"id":441,"slug":"alicante","name":"Аліканте","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":75000,"profile":{"city_type":"Mediterranean port city in Spain","access":["Alicante Airport (ALC), 9 km from the city"],"sources":["https://en.wikipedia.org/wiki/Alicante","https://en.wikipedia.org/wiki/Alicante%E2%80%93Elche_Airport"],"checked_at":"2026-11-03","status":"ok"}},{"id":98,"slug":"barcelona","name":"Барселона","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":85000,"profile":{"city_type":"Mediterranean coastal city in Spain","access":["Barcelona Airport (BCN), 15 km southwest of city center"],"sources":["https://en.wikipedia.org/wiki/Barcelona","https://en.wikipedia.org/wiki/Barcelona–El_Prat_Airport"],"checked_at":"2026-11-03","status":"ok"}}],"offers":{"active":1,"active_with_related":1,"hospital_nights_median":35,"days_in_country_median":{"status":"missing","reason":"fewer than 10 offers with hotel days"},"top_offers":[{"id":"5d6900aa59436a170a091f8c","clinic_id":278,"clinic_listed":true,"price":252989,"nights":35,"transfer":{"status":"missing","reason":"not_collected"},"tests":{"status":"missing","reason":"not_collected"},"meds":{"status":"missing","reason":"not_collected"},"aftercare":{"status":"missing","reason":"not_collected"},"guarantee":{"status":"missing","reason":"not_collected"},"included":["Individual chamber"],"excluded":["Transfer is not included"],"other_services":"When a related donor is available, the first priority is to confirm that allogeneic transplantation is truly indicated, assess the current disease status, and establish whether the family donor is sufficiently compatible. I recommend evaluation with Prof. Luis Madero at Hospital Universitario Quirónsalud Madrid, where the case can be reviewed within a dedicated pediatric hemato-oncology pathway. Why Prof. Luis Madero • Head of Pediatric Hemato-Oncology at Hospital Universitario Quirónsalud Madrid. • Head of Pediatric Hemato-Oncology and Hematopoietic Transplantation at Hospital Niño Jesús in Madrid. • Professor of Pediatrics at Universidad Autónoma de Madrid. • Author of more than 200 international scientific publications, with extensive experience in childhood leukemia, lymphoma, bone marrow disorders and hematopoietic transplantation. Why Quirónsalud Madrid The hospital has a dedicated Pediatric Hemato-Oncology Service and can coordinate hematology, pediatrics, intensive care, transfusion medicine, laboratory diagnostics and specialist support within the same hospital. For transplantation, the team evaluates the patient and potential related donor together, including HLA compatibility, infectious screening and organ-function testing before treatment is approved. Evaluation and treatment package • Consultation with Prof. Luis Madero • Review of bone marrow biopsy, pathology, cytogenetics and molecular studies. • Complete blood count, biochemistry and coagulation profile. • HLA typing of the patient and related donor. • Donor medical assessment and infectious-disease screening. • Cardiac, pulmonary, renal and liver assessment. • Bone marrow examination if an updated evaluation is required. • Conditioning chemotherapy. • Collection of hematopoietic stem cells from the related donor. • Allogeneic stem-cell infusion. • Protective inpatient hospitalization during marrow recovery. • Blood-product and anti-infective support. • Prevention and monitoring of graft-versus-host disease. • Early post-transplant follow-up. • Complete pre-transplant patient and donor evaluation • Related-donor allogeneic bone marrow/stem-cell transplantation","is_package":true}],"packages":[{"id":"5d6900aa59436a170a091f8c","clinic_id":278,"clinic_listed":true,"price":252989,"nights":35,"transfer":{"status":"missing","reason":"not_collected"},"tests":{"status":"missing","reason":"not_collected"},"meds":{"status":"missing","reason":"not_collected"},"aftercare":{"status":"missing","reason":"not_collected"},"guarantee":{"status":"missing","reason":"not_collected"},"included":["Individual chamber"],"excluded":["Transfer is not included"],"other_services":"When a related donor is available, the first priority is to confirm that allogeneic transplantation is truly indicated, assess the current disease status, and establish whether the family donor is sufficiently compatible. I recommend evaluation with Prof. Luis Madero at Hospital Universitario Quirónsalud Madrid, where the case can be reviewed within a dedicated pediatric hemato-oncology pathway. Why Prof. Luis Madero • Head of Pediatric Hemato-Oncology at Hospital Universitario Quirónsalud Madrid. • Head of Pediatric Hemato-Oncology and Hematopoietic Transplantation at Hospital Niño Jesús in Madrid. • Professor of Pediatrics at Universidad Autónoma de Madrid. • Author of more than 200 international scientific publications, with extensive experience in childhood leukemia, lymphoma, bone marrow disorders and hematopoietic transplantation. Why Quirónsalud Madrid The hospital has a dedicated Pediatric Hemato-Oncology Service and can coordinate hematology, pediatrics, intensive care, transfusion medicine, laboratory diagnostics and specialist support within the same hospital. For transplantation, the team evaluates the patient and potential related donor together, including HLA compatibility, infectious screening and organ-function testing before treatment is approved. Evaluation and treatment package • Consultation with Prof. Luis Madero • Review of bone marrow biopsy, pathology, cytogenetics and molecular studies. • Complete blood count, biochemistry and coagulation profile. • HLA typing of the patient and related donor. • Donor medical assessment and infectious-disease screening. • Cardiac, pulmonary, renal and liver assessment. • Bone marrow examination if an updated evaluation is required. • Conditioning chemotherapy. • Collection of hematopoietic stem cells from the related donor. • Allogeneic stem-cell infusion. • Protective inpatient hospitalization during marrow recovery. • Blood-product and anti-infective support. • Prevention and monitoring of graft-versus-host disease. • Early post-transplant follow-up. • Complete pre-transplant patient and donor evaluation • Related-donor allogeneic bone marrow/stem-cell transplantation","is_package":true}],"related_packages":{"status":"missing","reason":"not_collected"},"other_packages":{"status":"missing","reason":"not_classified"}},"medical":{"indications":["Acute myeloid and acute lymphoblastic leukemia in appropriate risk categories","Myelodysplastic syndromes and some chronic myeloid and lymphoid malignancies","Severe aplastic anemia","Inherited disorders such as thalassemia, sickle cell, severe immunodeficiency","Selected relapsed lymphomas or myeloma in specific circumstances"],"contraindications":["Severe uncontrolled infection","Severe organ dysfunction (heart, lung, liver, kidney) that precludes conditioning","Poor performance status or limited life expectancy from other causes","Refractory advanced disease unlikely to benefit from transplant (relative)","No suitably matched, medically fit related donor"],"operation_hours":{"min":1,"max":4,"unit":"hours","qualifier":"Marrow infusion takes hours; donor harvest takes about 1–2 hours; conditioning spans several days separately."},"anesthesia":["general"],"sessions_or_stages":{"sessions":{"min":1,"max":1,"unit":"visits","qualifier":"One marrow infusion after conditioning; a second transplant is only for graft failure."},"stages":[{"code":"workup","label":"Donor and patient HLA typing and fitness evaluation","after":{"min":0,"max":30,"unit":"days","qualifier":"Days from first evaluation to admission; completed before conditioning."}},{"code":"conditioning","label":"Conditioning chemotherapy with or without radiation","after":{"min":0,"max":2,"unit":"days","qualifier":"Starts at admission; runs several days before infusion."}},{"code":"infusion","label":"Donor marrow harvest and intravenous infusion","after":{"min":7,"max":9,"unit":"days","qualifier":"Day zero, after conditioning; about 7–9 days after admission."}},{"code":"engraftment","label":"Neutropenia and engraftment monitoring","after":{"min":21,"max":37,"unit":"days","qualifier":"Counts recover about 2–4 weeks after infusion; counted from admission."}},{"code":"early_outpatient","label":"Outpatient GVHD and infection monitoring","after":{"min":30,"max":120,"unit":"days","qualifier":"Stay near center about 100 days."}}],"qualifier":"Single transplant, with conditioning beforehand and about 100 days of monitoring after."},"hospital_nights":{"value":35,"source":"offers","parsed_details":{"min":21,"max":42,"unit":"nights","qualifier":"Inpatient stay from conditioning through engraftment; varies with complications and center practice."}},"treatment_conditions":["inpatient"],"rehabilitation_days":{"min":90,"max":180,"unit":"days","qualifier":"Return to basic daily function; depends on conditioning intensity, GVHD and complications."},"fly_home_after_days":{"min":100,"max":120,"unit":"days","qualifier":"Typically after about day 100 if engrafted, GVHD controlled and immunosuppression stable."},"back_to_work_days":{"min":180,"max":365,"unit":"days","qualifier":"Depends on GVHD, immunosuppression, job type and infection risk; many need a year or more."},"exercise_resume_weeks":{"min":12,"max":26,"unit":"weeks","qualifier":"Light walking earlier; structured exercise after discharge depends on fatigue, GVHD and team clearance."},"final_result_months":{"min":12,"max":24,"unit":"months","qualifier":"Full immune recovery and disease-response confirmation; often 1–2 years, depends on GVHD and immunosuppression taper."},"result_longevity":"Successful engraftment gives lifelong donor-derived blood production. Disease cure depends on diagnosis and risk, with relapse most likely in the first two years.","main_risks":["Infections during neutropenia and prolonged immunosuppression","Acute and chronic graft-versus-host disease","Graft failure or rejection","Conditioning toxicity: mucositis, nausea, organ damage, veno-occlusive disease","Disease relapse","Bleeding and need for transfusions","Infertility and late effects including secondary cancers","Treatment-related mortality"],"complication_rate_pct":{"min":40,"max":70,"unit":"percent","qualifier":"Grade II-IV acute GVHD, serious infection or organ toxicity within first year; non-relapse mortality about 10-20%."},"revision_rate_pct":{"min":2,"max":10,"unit":"percent","qualifier":"Graft failure or rejection needing second transplant or donor cell boost; higher in non-malignant and high-risk disease."},"success":{"metric":"Overall survival after related-donor marrow transplant","value":55,"horizon":"2 years","source":{"status":"missing","reason":"not_collected"},"evidence_status":"limited"},"scars":"No surgical scars for the recipient, only a small mark from the central venous catheter. The donor has tiny puncture marks at the pelvic harvest sites.","pain":"The marrow infusion itself is usually painless; discomfort mainly comes from conditioning-related mucositis, nausea and GVHD, managed with supportive medications.","preparation":["HLA typing and suitability evaluation of patient and donor","Disease status and organ function assessment (heart, lung, liver, kidney)","Infection screening and dental evaluation","Central venous catheter placement","Conditioning chemotherapy, with or without radiation, before infusion","Counseling on fertility preservation and informed consent"],"recovery_timeline":[{"phase":"Conditioning","description":"Chemotherapy with or without total body irradiation over several days before marrow infusion.","restrictions":["Inpatient isolation precautions"]},{"phase":"Infusion and neutropenia","description":"Donor marrow infused intravenously; blood counts fall then engraftment typically occurs after about 2–4 weeks, with supportive care and transfusions.","restrictions":["Protective isolation","Strict infection precautions"]},{"phase":"Early post-discharge","description":"Frequent outpatient visits, immunosuppression and monitoring for GVHD and infection over the first 3 months.","restrictions":["Avoid crowds and infection exposure","Diet and medication restrictions per team","Stay near transplant center"]},{"phase":"Long-term recovery","description":"Gradual immune recovery over months to a year or more; immunosuppression tapered if no GVHD.","restrictions":["Vaccination schedule re-started per team","Sun protection and ongoing surveillance"]}],"follow_up_visits":[{"purpose":"assessment","requirement":"routine","after":{"min":28,"max":42,"unit":"days","qualifier":"Engraftment and chimerism check, usually before discharge and in early outpatient visits."}},{"purpose":"other","requirement":"routine","after":{"min":30,"max":100,"unit":"days","qualifier":"Frequent outpatient visits for counts, GVHD, infection and catheter care."}},{"purpose":"result_review","requirement":"routine","after":{"min":100,"max":120,"unit":"days","qualifier":"Day-100 evaluation with marrow, chimerism and disease response assessment."}},{"purpose":"other","requirement":"conditional","after":{"min":180,"max":365,"unit":"days","qualifier":"Visits for GVHD flares, infections or relapse concerns, and later surveillance."}}],"sources":{"status":"missing","reason":"not_collected"},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Ask whether a doctor is always present in the clinic and whether a high dependency or intensive care unit exists","scope":"treatment_abroad","source":{"url":"https://www.bapras.org.uk/public/patient-information/cosmetic-surgery/cosmetic-surgery-abroad","host":"bapras.org.uk","quote":"Is there always a doctor in the clinic and is there a high dependency or intensive care unit?","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C2","text":"Ask whether the surgeon and the facility use a surgical safety checklist, which can reduce complications","scope":"treatment_abroad","source":{"url":"https://www.isaps.org/discover/patients-home/considering-your-procedure-abroad/finding-a-surgeon-abroad/","host":"isaps.org","quote":"Do the surgeon and his/her facility use a safety checklist?","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C3","text":"Decide before you travel where check-ups after the operation will take place, because follow-up abroad may be missing or weaker","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/conditions/cosmetic-procedures/cosmetic-surgery-abroad/","host":"nhs.uk","quote":"You need to think about where check-ups will take place.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"An advert or information that guarantees complete success should raise concerns","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Any advert or information that guarantees complete success should raise concerns.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"F2","text":"Forceful persuasion or cheap, time-limited offers pushing you into a quick decision","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Don’t be pressured into quick decisions either through forceful persuasion or cheap, time limited offers.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"F3","text":"A price that sounds too good to be true probably is","scope":"treatment_abroad","source":{"url":"https://www.plasticsurgery.org/news/articles/will-economic-uncertainty-drive-more-patients-overseas-for-plastic-surgery-what-to-consider-and-how-to-stretch-your-dollar-back-home","host":"plasticsurgery.org","quote":"If the price sounds too good to be true, it probably is.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"warning_signs":{"status":"ok","items":[{"id":"W1","text":"Abdominal cramps","urgency":"contact_clinic","general":false,"source":{"url":"https://my.clevelandclinic.org/health/treatments/22790-allogeneic-stem-cell-transplantation","host":"my.clevelandclinic.org","quote":"Abdominal cramps Diarrhea Itchy skin rash Nausea and vomiting Your skin and/or eyes are turning yellow ( jaundice )","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"W2","text":"Diarrhea","urgency":"contact_clinic","general":false,"source":{"url":"https://my.clevelandclinic.org/health/treatments/22790-allogeneic-stem-cell-transplantation","host":"my.clevelandclinic.org","quote":"Abdominal cramps Diarrhea Itchy skin rash Nausea and vomiting Your skin and/or eyes are turning yellow ( jaundice )","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"W3","text":"Itchy skin rash","urgency":"contact_clinic","general":false,"source":{"url":"https://my.clevelandclinic.org/health/treatments/22790-allogeneic-stem-cell-transplantation","host":"my.clevelandclinic.org","quote":"Abdominal cramps Diarrhea Itchy skin rash Nausea and vomiting Your skin and/or eyes are turning yellow ( jaundice )","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"W4","text":"Yellow skin or eyes","urgency":"contact_clinic","general":false,"source":{"url":"https://my.clevelandclinic.org/health/treatments/22790-allogeneic-stem-cell-transplantation","host":"my.clevelandclinic.org","quote":"Abdominal cramps Diarrhea Itchy skin rash Nausea and vomiting Your skin and/or eyes are turning yellow ( jaundice )","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"W5","text":"Fever of 100.4 degrees Fahrenheit or higher","urgency":"contact_clinic","general":true,"source":{"url":"https://my.clevelandclinic.org/health/treatments/22790-allogeneic-stem-cell-transplantation","host":"my.clevelandclinic.org","quote":"Chills Coughing, sneezing or runny nose Dizziness or feeling lightheaded Feeling short of breath Fever that’s 100.4 degrees Fahrenheit (38 degrees Celsius) or higher","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"take_home":{"status":"ok","items":[{"id":"T1","text":"Home doctor needs the clinic's follow-up recommendations in a written discharge summary","document":"discharge summary","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"When you have treatment abroad, you must ask the treatment provider for their follow-up recommendations documented within a written discharge summary in English.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T2","text":"Ask for copies of all prescriptions before you leave","document":"prescription copies","source":{"url":"https://travelhealthpro.org.uk/news/699/travelling-abroad-for-treatment","host":"travelhealthpro.org.uk","quote":"Remember to ask for copies of all your treatment records, including prescriptions, scans and x-rays before you leave.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"preop_tests":{"status":"ok","items":[{"id":"T1","name":"HLA typing","aliases":["HLA typing","HLA typing of patient and donor","HLA typing of patient and sibling donors","HLA"],"kind":"lab","origin":[{"field":"preparation","text":"HLA typing and suitability evaluation of patient and donor"},{"field":"initial_assessment_documents","text":"HLA typing of patient and sibling donors"}],"what_it_checks":{"text":"Checks whether the donor's HLA alleles match the patient's","source":{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4345295/","host":"pmc.ncbi.nlm.nih.gov","quote":"All patients received complete HLA-matched allografts from siblings except three AML patients, who each had one mismatched HLA allele in the allograft from sibling donors.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T2","name":"Dental examination","aliases":["Dental examination","Dental evaluation"],"kind":"exam","origin":[{"field":"preparation","text":"Infection screening and dental evaluation"}],"what_it_checks":{"text":"Stabilizes teeth to reduce infection risk during neutropenia","source":{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10902180/","host":"pmc.ncbi.nlm.nih.gov","quote":"Dental examination and stabilization is performed prior to allogeneic hematopoietic cell transplantation to decrease infection risk during neutropenia.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T3","name":"Bone marrow biopsy","aliases":["Bone marrow biopsy","BMB"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"Bone marrow biopsy and pathology report"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T4","name":"Cytogenetic testing","aliases":["Cytogenetic testing","Cytogenetic"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"Cytogenetic and molecular mutation report"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T5","name":"Molecular mutation testing","aliases":["Molecular mutation testing","Molecular mutation"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"Cytogenetic and molecular mutation report"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T6","name":"Complete blood count","aliases":["Complete blood count","CBC","full blood count"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"Recent complete blood count results"}],"what_it_checks":{"text":"Checks blood cell counts in the pre-transplant workup","source":{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4345295/","host":"pmc.ncbi.nlm.nih.gov","quote":"Pre-transplant work up for all patients and donors consisted of standard blood work, including complete blood counts (CBC), liver function tests, blood grouping and coagulation profile.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"type":"always","text":"Always","source":{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4345295/","host":"pmc.ncbi.nlm.nih.gov","quote":"Pre-transplant work up for all patients and donors consisted of standard blood work, including complete blood counts (CBC), liver function tests, blood grouping and coagulation profile.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"test_prep":null},{"id":"T7","name":"Blood tests","aliases":["Blood tests"],"kind":"lab","origin":[{"field":"packages","text":"Blood tests"}],"what_it_checks":{"text":"Checks blood counts, liver function, blood group and clotting before transplant","source":{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4345295/","host":"pmc.ncbi.nlm.nih.gov","quote":"Pre-transplant work up for all patients and donors consisted of standard blood work, including complete blood counts (CBC), liver function tests, blood grouping and coagulation profile.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"type":"always","text":"Always","source":{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4345295/","host":"pmc.ncbi.nlm.nih.gov","quote":"Pre-transplant work up for all patients and donors consisted of standard blood work, including complete blood counts (CBC), liver function tests, blood grouping and coagulation profile.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"test_prep":null}],"checked_at":"2026-11-17","next_check_at":"2027-11-17","version":1},"prep_in_advance":{"status":"ok","items":[{"id":"P1","action":"Tell the team about every medicine, vitamin and supplement you take","why":"Some medicines can affect recovery and response to anesthesia","who_decides":"","source":{"url":"https://www.facs.org/for-patients/preparing-for-surgery/","host":"facs.org","quote":"Some medications can affect your recovery and response to anesthesia.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"P2","action":"Ask your prescriber which regular medicines may need adjusting before the procedure","why":"Some regular medicines may need adjusting before the operation","who_decides":"prescriber","source":{"url":"https://www.facs.org/for-patients/preparing-for-surgery/","host":"facs.org","quote":"Your medications may have to be adjusted before your operation.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"P3","action":"Stop smoking before the operation","why":"Smoking increases the risk of problems during and after surgery","who_decides":"","source":{"url":"https://www.facs.org/for-patients/preparing-for-surgery/","host":"facs.org","quote":"Smoking increases your risk of problems during and after your operation.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}],"checked_at":"2026-11-17","next_check_at":"2027-11-17","version":1},"visit_and_day":{"status":"ok","has_procedure_day":true,"items":[{"id":"V1","text":"The transplant usually takes place the day after conditioning therapy finishes","anesthesia":"any","source":{"url":"https://www.nhs.uk/tests-and-treatments/stem-cell-or-bone-marrow-transplants/how-its-done/","host":"nhs.uk","quote":"The transplant usually happens the day after your conditioning therapy has finished.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"V2","text":"Before a general anesthetic, you are usually asked to attend a pre-operative assessment a few weeks before the procedure","anesthesia":"general","source":{"url":"https://www.nhs.uk/tests-and-treatments/general-anaesthesia/","host":"nhs.uk","quote":"You'll usually be asked to go to an appointment a few weeks before your procedure (a pre-operative assessment).","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"V3","text":"Before general anesthesia, you may be told not to eat or drink anything after midnight, unless only local anesthesia is used","anesthesia":"general","source":{"url":"https://madeforthismoment.asahq.org/preparing-for-surgery/prep/preparing-for-surgery-checklist/","host":"madeforthismoment.asahq.org","quote":"Unless youâre having only local anesthesia, you may be told not to eat or drink anything after midnight before your procedure.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}],"checked_at":"2026-11-17","next_check_at":"2027-11-17","version":1},"if_something_changes":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-17","next_check_at":"2027-02-15"}},"parsed_details":{"procedure_type":"therapy","fields":{"anesthesia":["general"],"back_to_work_days":{"min":180,"max":365,"unit":"days","qualifier":"Depends on GVHD, immunosuppression, job type and infection risk; many need a year or more."},"complication_rate_pct":{"min":40,"max":70,"unit":"percent","qualifier":"Grade II-IV acute GVHD, serious infection or organ toxicity within first year; non-relapse mortality about 10-20%."},"contraindications":["Severe uncontrolled infection","Severe organ dysfunction (heart, lung, liver, kidney) that precludes conditioning","Poor performance status or limited life expectancy from other causes","Refractory advanced disease unlikely to benefit from transplant (relative)","No suitably matched, medically fit related donor"],"days_in_clinic":{"min":21,"max":42,"unit":"nights","qualifier":"Inpatient stay from conditioning through engraftment; varies with complications and center practice."},"diagnostic_duration_minutes":null,"diagnostic_preparation":null,"diagnostic_referral_needed":null,"diagnostic_result_time_hours":null,"exercise_resume_weeks":{"min":12,"max":26,"unit":"weeks","qualifier":"Light walking earlier; structured exercise after discharge depends on fatigue, GVHD and team clearance."},"final_result_months":{"min":12,"max":24,"unit":"months","qualifier":"Full immune recovery and disease-response confirmation; often 1–2 years, depends on GVHD and immunosuppression taper."},"fly_home_after_days":{"min":100,"max":120,"unit":"days","qualifier":"Typically after about day 100 if engrafted, GVHD controlled and immunosuppression stable."},"follow_up_visits":[{"purpose":"assessment","after":{"min":28,"max":42,"unit":"days","qualifier":"Engraftment and chimerism check, usually before discharge and in early outpatient visits."},"requirement":"routine"},{"purpose":"other","after":{"min":30,"max":100,"unit":"days","qualifier":"Frequent outpatient visits for counts, GVHD, infection and catheter care."},"requirement":"routine"},{"purpose":"result_review","after":{"min":100,"max":120,"unit":"days","qualifier":"Day-100 evaluation with marrow, chimerism and disease response assessment."},"requirement":"routine"},{"purpose":"other","after":{"min":180,"max":365,"unit":"days","qualifier":"Visits for GVHD flares, infections or relapse concerns, and later surveillance."},"requirement":"conditional"}],"indications":["Acute myeloid and acute lymphoblastic leukemia in appropriate risk categories","Myelodysplastic syndromes and some chronic myeloid and lymphoid malignancies","Severe aplastic anemia","Inherited disorders such as thalassemia, sickle cell, severe immunodeficiency","Selected relapsed lymphomas or myeloma in specific circumstances"],"main_risks":["Infections during neutropenia and prolonged immunosuppression","Acute and chronic graft-versus-host disease","Graft failure or rejection","Conditioning toxicity: mucositis, nausea, organ damage, veno-occlusive disease","Disease relapse","Bleeding and need for transfusions","Infertility and late effects including secondary cancers","Treatment-related mortality"],"pain":"The marrow infusion itself is usually painless; discomfort mainly comes from conditioning-related mucositis, nausea and GVHD, managed with supportive medications.","preparation":["HLA typing and suitability evaluation of patient and donor","Disease status and organ function assessment (heart, lung, liver, kidney)","Infection screening and dental evaluation","Central venous catheter placement","Conditioning chemotherapy, with or without radiation, before infusion","Counseling on fertility preservation and informed consent"],"recovery_timeline":[{"phase":"Conditioning","description":"Chemotherapy with or without total body irradiation over several days before marrow infusion.","restrictions":["Inpatient isolation precautions"]},{"phase":"Infusion and neutropenia","description":"Donor marrow infused intravenously; blood counts fall then engraftment typically occurs after about 2–4 weeks, with supportive care and transfusions.","restrictions":["Protective isolation","Strict infection precautions"]},{"phase":"Early post-discharge","description":"Frequent outpatient visits, immunosuppression and monitoring for GVHD and infection over the first 3 months.","restrictions":["Avoid crowds and infection exposure","Diet and medication restrictions per team","Stay near transplant center"]},{"phase":"Long-term recovery","description":"Gradual immune recovery over months to a year or more; immunosuppression tapered if no GVHD.","restrictions":["Vaccination schedule re-started per team","Sun protection and ongoing surveillance"]}],"rehabilitation_days":{"min":90,"max":180,"unit":"days","qualifier":"Return to basic daily function; depends on conditioning intensity, GVHD and complications."},"result_longevity":"Successful engraftment gives lifelong donor-derived blood production. Disease cure depends on diagnosis and risk, with relapse most likely in the first two years.","revision_rate_pct":{"min":2,"max":10,"unit":"percent","qualifier":"Graft failure or rejection needing second transplant or donor cell boost; higher in non-malignant and high-risk disease."},"scars":"No surgical scars for the recipient, only a small mark from the central venous catheter. The donor has tiny puncture marks at the pelvic harvest sites.","sessions_or_stages":{"sessions":{"min":1,"max":1,"unit":"visits","qualifier":"One marrow infusion after conditioning; a second transplant is only for graft failure."},"stages":[{"code":"workup","label":"Donor and patient HLA typing and fitness evaluation","after":{"min":0,"max":30,"unit":"days","qualifier":"Days from first evaluation to admission; completed before conditioning."}},{"code":"conditioning","label":"Conditioning chemotherapy with or without radiation","after":{"min":0,"max":2,"unit":"days","qualifier":"Starts at admission; runs several days before infusion."}},{"code":"infusion","label":"Donor marrow harvest and intravenous infusion","after":{"min":7,"max":9,"unit":"days","qualifier":"Day zero, after conditioning; about 7–9 days after admission."}},{"code":"engraftment","label":"Neutropenia and engraftment monitoring","after":{"min":21,"max":37,"unit":"days","qualifier":"Counts recover about 2–4 weeks after infusion; counted from admission."}},{"code":"early_outpatient","label":"Outpatient GVHD and infection monitoring","after":{"min":30,"max":120,"unit":"days","qualifier":"Stay near center about 100 days."}}],"qualifier":"Single transplant, with conditioning beforehand and about 100 days of monitoring after."},"success":{"metric":"Overall survival after related-donor marrow transplant","value":55,"unit":"percent","horizon":"2 years","population":"Adults with leukemia or marrow failure, matched sibling donor, standard-risk","evidence_status":"limited"},"techniques":[{"name":"Myeloablative conditioning followed by related-donor marrow infusion","suits_whom":"Typically younger, fit patients with high-risk malignant or marrow failure disease.","recovery":"Longer neutropenia; inpatient stay of several weeks."},{"name":"Reduced-intensity conditioning followed by related-donor marrow infusion","suits_whom":"Older or less fit patients, or those with comorbidities.","recovery":"Less conditioning toxicity; still requires weeks of monitoring and GVHD vigilance."}],"treatment_conditions":["inpatient"],"treatment_duration_hours":{"min":1,"max":4,"unit":"hours","qualifier":"Marrow infusion takes hours; donor harvest takes about 1–2 hours; conditioning spans several days separately."},"initial_assessment_documents":["Bone marrow biopsy and pathology report","Cytogenetic and molecular mutation report","Recent complete blood count results","HLA typing of patient and sibling donors","Prior chemotherapy and transplant treatment summary","Heart, lung, liver and kidney test results"],"travel_trips":{"min":1,"max":3,"one_trip_possible":true,"qualifier":"Donor and patient travel together; one stay covers workup, transplant and about 100 days' monitoring. Some centers split follow-up."},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Ask whether a doctor is always present in the clinic and whether a high dependency or intensive care unit exists","scope":"treatment_abroad","source":{"url":"https://www.bapras.org.uk/public/patient-information/cosmetic-surgery/cosmetic-surgery-abroad","host":"bapras.org.uk","quote":"Is there always a doctor in the clinic and is there a high dependency or intensive care unit?","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C2","text":"Ask whether the surgeon and the facility use a surgical safety checklist, which can reduce complications","scope":"treatment_abroad","source":{"url":"https://www.isaps.org/discover/patients-home/considering-your-procedure-abroad/finding-a-surgeon-abroad/","host":"isaps.org","quote":"Do the surgeon and his/her facility use a safety checklist?","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C3","text":"Decide before you travel where check-ups after the operation will take place, because follow-up abroad may be missing or weaker","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/conditions/cosmetic-procedures/cosmetic-surgery-abroad/","host":"nhs.uk","quote":"You need to think about where check-ups will take place.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"An advert or information that guarantees complete success should raise concerns","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Any advert or information that guarantees complete success should raise concerns.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"F2","text":"Forceful persuasion or cheap, time-limited offers pushing you into a quick decision","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Don’t be pressured into quick decisions either through forceful persuasion or cheap, time limited offers.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"F3","text":"A price that sounds too good to be true probably is","scope":"treatment_abroad","source":{"url":"https://www.plasticsurgery.org/news/articles/will-economic-uncertainty-drive-more-patients-overseas-for-plastic-surgery-what-to-consider-and-how-to-stretch-your-dollar-back-home","host":"plasticsurgery.org","quote":"If the price sounds too good to be true, it probably is.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"warning_signs":{"status":"ok","items":[{"id":"W1","text":"Abdominal cramps","urgency":"contact_clinic","general":false,"source":{"url":"https://my.clevelandclinic.org/health/treatments/22790-allogeneic-stem-cell-transplantation","host":"my.clevelandclinic.org","quote":"Abdominal cramps Diarrhea Itchy skin rash Nausea and vomiting Your skin and/or eyes are turning yellow ( jaundice )","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"W2","text":"Diarrhea","urgency":"contact_clinic","general":false,"source":{"url":"https://my.clevelandclinic.org/health/treatments/22790-allogeneic-stem-cell-transplantation","host":"my.clevelandclinic.org","quote":"Abdominal cramps Diarrhea Itchy skin rash Nausea and vomiting Your skin and/or eyes are turning yellow ( jaundice )","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"W3","text":"Itchy skin rash","urgency":"contact_clinic","general":false,"source":{"url":"https://my.clevelandclinic.org/health/treatments/22790-allogeneic-stem-cell-transplantation","host":"my.clevelandclinic.org","quote":"Abdominal cramps Diarrhea Itchy skin rash Nausea and vomiting Your skin and/or eyes are turning yellow ( jaundice )","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"W4","text":"Yellow skin or eyes","urgency":"contact_clinic","general":false,"source":{"url":"https://my.clevelandclinic.org/health/treatments/22790-allogeneic-stem-cell-transplantation","host":"my.clevelandclinic.org","quote":"Abdominal cramps Diarrhea Itchy skin rash Nausea and vomiting Your skin and/or eyes are turning yellow ( jaundice )","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"W5","text":"Fever of 100.4 degrees Fahrenheit or higher","urgency":"contact_clinic","general":true,"source":{"url":"https://my.clevelandclinic.org/health/treatments/22790-allogeneic-stem-cell-transplantation","host":"my.clevelandclinic.org","quote":"Chills Coughing, sneezing or runny nose Dizziness or feeling lightheaded Feeling short of breath Fever that’s 100.4 degrees Fahrenheit (38 degrees Celsius) or higher","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"take_home":{"status":"ok","items":[{"id":"T1","text":"Home doctor needs the clinic's follow-up recommendations in a written discharge summary","document":"discharge summary","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"When you have treatment abroad, you must ask the treatment provider for their follow-up recommendations documented within a written discharge summary in English.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T2","text":"Ask for copies of all prescriptions before you leave","document":"prescription copies","source":{"url":"https://travelhealthpro.org.uk/news/699/travelling-abroad-for-treatment","host":"travelhealthpro.org.uk","quote":"Remember to ask for copies of all your treatment records, including prescriptions, scans and x-rays before you leave.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"alternatives":{"status":"ok","items":[{"id":"A1","text":"You have severe aplastic anemia and no matched sibling donor","name":"Immunosuppressive therapy","source":{"url":"https://consultqd.clevelandclinic.org/improving-therapies-for-children-with-severe-aplastic-anemia","host":"consultqd.clevelandclinic.org","quote":"Immunosuppressive therapy (IST) with horse antithymocyte globulin and cyclosporine currently remains the standard therapy for children with SAA who lack matched sibling donors.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200},"operation_id":null}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"technique_details":{"status":"ok","items":[{"id":"myeloablative-conditioning","name":"Myeloablative conditioning followed by related-donor marrow infusion","how_it_works":{"text":"Pre-transplant treatment kills cancer cells and makes marrow room","source":{"url":"https://my.clevelandclinic.org/health/treatments/22790-allogeneic-stem-cell-transplantation","host":"my.clevelandclinic.org","quote":"Kills cancer cells in your body Makes room in your bone marrow for new blood stem cells to grow Suppresses your immune system to reduce the chance your body will reject the donated stem cells","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}},{"id":"reduced-intensity","name":"Reduced-intensity conditioning followed by related-donor marrow infusion","how_it_works":{"text":"Patients receive lower doses of chemotherapy, with or without lower radiation","source":{"url":"https://www.mskcc.org/cancer-care/patient-education/allogeneic-stem-cell-transplantation","host":"mskcc.org","quote":"With a nonmyeloablative transplant, you'll get lower doses of chemotherapy with or without lower doses of radiation.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"preop_tests":{"status":"ok","items":[{"id":"T1","name":"HLA typing","aliases":["HLA typing","HLA typing of patient and donor","HLA typing of patient and sibling donors","HLA"],"kind":"lab","origin":[{"field":"preparation","text":"HLA typing and suitability evaluation of patient and donor"},{"field":"initial_assessment_documents","text":"HLA typing of patient and sibling donors"}],"what_it_checks":{"text":"Checks whether the donor's HLA alleles match the patient's","source":{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4345295/","host":"pmc.ncbi.nlm.nih.gov","quote":"All patients received complete HLA-matched allografts from siblings except three AML patients, who each had one mismatched HLA allele in the allograft from sibling donors.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T2","name":"Dental examination","aliases":["Dental examination","Dental evaluation"],"kind":"exam","origin":[{"field":"preparation","text":"Infection screening and dental evaluation"}],"what_it_checks":{"text":"Stabilizes teeth to reduce infection risk during neutropenia","source":{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10902180/","host":"pmc.ncbi.nlm.nih.gov","quote":"Dental examination and stabilization is performed prior to allogeneic hematopoietic cell transplantation to decrease infection risk during neutropenia.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T3","name":"Bone marrow biopsy","aliases":["Bone marrow biopsy","BMB"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"Bone marrow biopsy and pathology report"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T4","name":"Cytogenetic testing","aliases":["Cytogenetic testing","Cytogenetic"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"Cytogenetic and molecular mutation report"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T5","name":"Molecular mutation testing","aliases":["Molecular mutation testing","Molecular mutation"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"Cytogenetic and molecular mutation report"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T6","name":"Complete blood count","aliases":["Complete blood count","CBC","full blood count"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"Recent complete blood count results"}],"what_it_checks":{"text":"Checks blood cell counts in the pre-transplant workup","source":{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4345295/","host":"pmc.ncbi.nlm.nih.gov","quote":"Pre-transplant work up for all patients and donors consisted of standard blood work, including complete blood counts (CBC), liver function tests, blood grouping and coagulation profile.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"type":"always","text":"Always","source":{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4345295/","host":"pmc.ncbi.nlm.nih.gov","quote":"Pre-transplant work up for all patients and donors consisted of standard blood work, including complete blood counts (CBC), liver function tests, blood grouping and coagulation profile.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"test_prep":null},{"id":"T7","name":"Blood tests","aliases":["Blood tests"],"kind":"lab","origin":[{"field":"packages","text":"Blood tests"}],"what_it_checks":{"text":"Checks blood counts, liver function, blood group and clotting before transplant","source":{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4345295/","host":"pmc.ncbi.nlm.nih.gov","quote":"Pre-transplant work up for all patients and donors consisted of standard blood work, including complete blood counts (CBC), liver function tests, blood grouping and coagulation profile.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"type":"always","text":"Always","source":{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4345295/","host":"pmc.ncbi.nlm.nih.gov","quote":"Pre-transplant work up for all patients and donors consisted of standard blood work, including complete blood counts (CBC), liver function tests, blood grouping and coagulation profile.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"test_prep":null}],"checked_at":"2026-11-17","next_check_at":"2027-11-17","version":1},"prep_in_advance":{"status":"ok","items":[{"id":"P1","action":"Tell the team about every medicine, vitamin and supplement you take","why":"Some medicines can affect recovery and response to anesthesia","who_decides":"","source":{"url":"https://www.facs.org/for-patients/preparing-for-surgery/","host":"facs.org","quote":"Some medications can affect your recovery and response to anesthesia.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"P2","action":"Ask your prescriber which regular medicines may need adjusting before the procedure","why":"Some regular medicines may need adjusting before the operation","who_decides":"prescriber","source":{"url":"https://www.facs.org/for-patients/preparing-for-surgery/","host":"facs.org","quote":"Your medications may have to be adjusted before your operation.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"P3","action":"Stop smoking before the operation","why":"Smoking increases the risk of problems during and after surgery","who_decides":"","source":{"url":"https://www.facs.org/for-patients/preparing-for-surgery/","host":"facs.org","quote":"Smoking increases your risk of problems during and after your operation.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}],"checked_at":"2026-11-17","next_check_at":"2027-11-17","version":1},"visit_and_day":{"status":"ok","has_procedure_day":true,"items":[{"id":"V1","text":"The transplant usually takes place the day after conditioning therapy finishes","anesthesia":"any","source":{"url":"https://www.nhs.uk/tests-and-treatments/stem-cell-or-bone-marrow-transplants/how-its-done/","host":"nhs.uk","quote":"The transplant usually happens the day after your conditioning therapy has finished.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"V2","text":"Before a general anesthetic, you are usually asked to attend a pre-operative assessment a few weeks before the procedure","anesthesia":"general","source":{"url":"https://www.nhs.uk/tests-and-treatments/general-anaesthesia/","host":"nhs.uk","quote":"You'll usually be asked to go to an appointment a few weeks before your procedure (a pre-operative assessment).","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"V3","text":"Before general anesthesia, you may be told not to eat or drink anything after midnight, unless only local anesthesia is used","anesthesia":"general","source":{"url":"https://madeforthismoment.asahq.org/preparing-for-surgery/prep/preparing-for-surgery-checklist/","host":"madeforthismoment.asahq.org","quote":"Unless youâre having only local anesthesia, you may be told not to eat or drink anything after midnight before your procedure.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}],"checked_at":"2026-11-17","next_check_at":"2027-11-17","version":1},"if_something_changes":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-17","next_check_at":"2027-02-15"}}},"techniques":[{"id":"myeloablative-conditioning","name":"Myeloablative conditioning followed by related-donor marrow infusion","how_it_works":{"id":"H1","text":"Pre-transplant treatment kills cancer cells and makes marrow room","source":{"url":"https://my.clevelandclinic.org/health/treatments/22790-allogeneic-stem-cell-transplantation","host":"my.clevelandclinic.org","quote":"Kills cancer cells in your body Makes room in your bone marrow for new blood stem cells to grow Suppresses your immune system to reduce the chance your body will reject the donated stem cells","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Typically younger, fit patients with high-risk malignant or marrow failure disease.","price_from":160000,"recovery":"Longer neutropenia; inpatient stay of several weeks."},{"id":"reduced-intensity","name":"Reduced-intensity conditioning followed by related-donor marrow infusion","how_it_works":{"id":"H1","text":"Patients receive lower doses of chemotherapy, with or without lower radiation","source":{"url":"https://www.mskcc.org/cancer-care/patient-education/allogeneic-stem-cell-transplantation","host":"mskcc.org","quote":"With a nonmyeloablative transplant, you'll get lower doses of chemotherapy with or without lower doses of radiation.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Older or less fit patients, or those with comorbidities.","price_from":140000,"recovery":"Less conditioning toxicity; still requires weeks of monitoring and GVHD vigilance."}],"alternatives":{"status":"ok","items":[{"id":"A1","text":"You have severe aplastic anemia and no matched sibling donor","name":"Immunosuppressive therapy","source":{"url":"https://consultqd.clevelandclinic.org/improving-therapies-for-children-with-severe-aplastic-anemia","host":"consultqd.clevelandclinic.org","quote":"Immunosuppressive therapy (IST) with horse antithymocyte globulin and cyclosporine currently remains the standard therapy for children with SAA who lack matched sibling donors.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200},"operation_id":null}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"diagnostic":{"status":"not_applicable"},"country":{"why":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-11","next_check_at":"2027-02-09"},"travel":{"status":"ok","items":[{"id":"V1","item":"passport_validity","audience":"uk","volatile":true,"text":"The passport must have an expiry date at least 3 months after you plan to leave the Schengen area","source":{"url":"https://www.gov.uk/foreign-travel-advice/spain/entry-requirements","host":"gov.uk","quote":"have an ‘expiry date’ at least 3 months after the day you plan to leave the Schengen area (the expiry date does not need to be within 10 years of the date of issue)","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V2","item":"medicines","audience":"all","volatile":false,"text":"Carry prescription medication in its original packaging, along with your doctor's prescription","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Spain.html","host":"travel.state.gov","quote":"Always carry your prescription medication in original packaging, along with your doctor’s prescription.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V3","item":"prescriptions","audience":"us","volatile":false,"text":"Medications that require a prescription in the United States also require a local doctor's prescription in Spain","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Spain.html","host":"travel.state.gov","quote":"Medications requiring prescriptions in the United States also require a local doctor’s prescription in Spain.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V4","item":"ghic","audience":"uk","volatile":false,"text":"A GHIC or EHIC is needed to get medically necessary state healthcare in Spain","source":{"url":"https://www.gov.uk/foreign-travel-advice/spain/health","host":"gov.uk","quote":"To get medically necessary state healthcare in Spain, you need a Global Health Insurance Card ( GHIC ) or a European Health Insurance Card ( EHIC ).","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V5","item":"hospital_payment","audience":"all","volatile":false,"text":"Private hospitals usually require payment or proof of insurance or funds before admitting a patient","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Spain.html","host":"travel.state.gov","quote":"Private hospitals usually require payment or proof insurance or funds before admitting a patient.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V6","item":"emergency_number","audience":"all","volatile":false,"text":"Dial 112 and ask for an ambulance","source":{"url":"https://www.gov.uk/foreign-travel-advice/spain/health","host":"gov.uk","quote":"Dial 112 and ask for an ambulance.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-11","next_check_at":"2026-12-11","version":1},"other_countries_with_page":["azerbaijan","china","egypt","india","israel","republic-of-korea","turkey","united-kingdom","united-states"]},"often_combined_with":{"status":"missing","reason":"not_collected"},"reviews":{"avg_rating":4.69,"count":558,"scope":"clinic","rating_scale":5,"pros":{"status":"missing","reason":"not_collected"},"cons":{"status":"missing","reason":"not_collected"}},"current":{"seo_text":"<p>Allogenic bone marrow transplantation from a related donor in Spain typically costs from _op_177_price_from_ to _op_177_price_to_. The final price depends on the clinic tier, city, and the complexity of the patient's condition. In the US, similar procedures cost around _price_compare_US_average_ on average. Patients save around _price_percent_discount_% compared to the US. Costs in Spain typically include pre-transplant assessment, HLA typing, the transplant procedure, and hospitalization.</p>\n\n<ul>\n<li><strong>Clinic location:</strong> Costs in major medical hubs like Madrid and Barcelona vary by approximately 15-20%.</li>\n<li><strong>Hospitalization duration:</strong> Standard packages include 10 to 30 days of inpatient stay and meals.</li>\n<li><strong>Pediatric specialized care:</strong> Treatment for children in specialized hospitals can increase costs by 30-40%.</li>\n<li><strong>Pre-transplant evaluation:</strong> Comprehensive diagnostic workups and donor matching sessions add to the initial budget.</li>\n</ul>\n\n<p><strong>Bookimed Expert Insight:</strong> Choosing a first-certified JCI hospital like Clinica Universidad de Navarra ensures top-tier safety standards. While pediatric specialists like Dr. Luis Madero at Quironsalud Madrid represent a higher investment, their 5-star rated expertise offers significant value. Patients should look for packages that include at least 10 days of hospitalization to manage initial recovery phases effectively.</p>","faq":[{"q":"What is an allogeneic bone marrow transplant from a related donor?","a":"<p>An allogeneic bone marrow transplant from a related donor replaces diseased blood-forming cells with healthy stem cells from a genetically matched family member. This procedure treats blood cancers and severe hematologic disorders using intravenous infusions after intensive chemotherapy prepares the patient.</p> <ul> <li><strong>Donor matching:</strong> Siblings provide the best Human Leukocyte Antigen (HLA) match for patients.</li> <li><strong>Conditioning phase:</strong> High-dose chemotherapy or radiation destroys diseased marrow before the infusion occurs.</li> <li><strong>Cell collection:</strong> Stem cells are collected from donor bone marrow or peripheral blood.</li> <li><strong>Hospital stay:</strong> Patients typically remain hospitalized for 10 days for initial monitoring.</li> <li><strong>Recovery timeline:</strong> Intensive recovery involves 30 days in-hospital and several months of outpatient visits.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While only 25% of patients find a family match, sibling donors remain the gold standard due to safety. Data shows fully matched siblings carry a Graft-Versus-Host Disease (GVHD) risk under 1%, significantly lower than the 10% risk seen with half-matched relatives.</p> <p><strong>Patient Consensus:</strong> Patients often find it surprising that they may inherit their donor's allergies or blood type. Most participants emphasize that while the process is intensive, matching with a sibling is the preferred and safest clinical path.</p>"},{"q":"What are the success rates for related-donor bone marrow transplants in Spain?","a":"<p>Related-donor bone marrow transplant success rates in Spain typically range from 70% to 80% for allogeneic procedures, with some cases reaching 90%. Success depends on disease type, patient age, and donor compatibility, with higher efficacy observed in treating acute myeloid leukemia and Hodgkin lymphoma.</p> <ul> <li><strong>Success rates:</strong> Typical allogeneic outcomes range from 70% to 80% depending on patient health.</li> <li><strong>Highest potential:</strong> Success reaches 90% in optimal cases using advanced haploidentical transplantation methods.</li> <li><strong>Hospital stay:</strong> Patients generally require a 10-day hospitalization period for monitoring and stabilization.</li> <li><strong>Global leadership:</strong> Spain maintains the world highest donor rate at 52.6 per million people.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Spain’s leadership in transplantation isn't just about surgery; it's about speed. Because Spain has the highest organ and tissue donor rate globally, clinics like SJD Barcelona and Navarra Hospital have shorter waiting times for confirmatory matching. This allows surgeons like Dr. Luis Madero to proceed with transplants faster than in many other European regions, which is a critical factor for aggressive leukemias.</p> <p><strong>Patient Consensus:</strong> Patients value Spain's world-leading transplant infrastructure and often emphasize that related-donor procedures offer better success chances compared to non-related matches.</p>"},{"q":"What are the advantages of choosing a related donor over an unrelated donor?","a":"<p>Choosing a related familial donor for allogeneic bone marrow transplantation provides vital biological benefits. Relatives offer much closer human leukocyte antigen matching. This high compatibility reduces graft-versus-host disease risks. Furthermore, family mobilization accelerates the preparation timeline. This immediate availability prevents dangerous oncology treatment delays in specialized centers.</p> <ul> <li><strong>Lower GVHD risk:</strong> Fully matched siblings reduce graft-versus-host disease incidence beneath 1%.</li> <li><strong>Rapid procurement:</strong> Family members mobilize faster than international registry searches.</li> <li><strong>Easy secondary access:</strong> Related donors remain reachable for subsequent donor lymphocyte infusions.</li> <li><strong>Healthier stem cells:</strong> Younger family relatives under 30 offer highly viable bone marrow grafts.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> When reviewing Spanish centers like SJD Barcelona, pediatric teams heavily emphasize sibling donors. Younger relatives provide healthier marrow, which is crucial for long-term transplant success.</p> <p><strong>Patient Consensus:</strong> Patients value the flexible scheduling and peace of mind that family donors provide. Knowing a relative is available for secondary lymphocyte infusions reduces post-transplant anxiety.</p>"},{"q":"How long is the typical inpatient stay after an allogeneic transplant in Spain?","a":"<p>The typical inpatient stay for an allogeneic transplant in Spain is 3 to 6 weeks. Patients often reach a median stay of 25 to 27 days depending on the stem cell source. Specialized centers like Quironsalud Madrid may offer focused 10-day intensive monitoring packages.</p> <ul> <li><strong>Bone marrow source:</strong> Expect an average stay of 27 days for traditional marrow sources.</li> <li><strong>Peripheral blood source:</strong> Recovery is often faster with an average stay of 25 days.</li> <li><strong>Engraftment milestone:</strong> Patients remain hospitalized until new stem cells produce blood cells.</li> <li><strong>Safety monitoring:</strong> Doctors provide continuous 24-hour care to manage infection risks or GVHD.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Spain ranks 4th globally for transplant requests on our platform. Some centers like Clinica Universidad de Navarra maintain top JCI standards while offering faster initial discharge protocols. Patients should prioritize clinics with high pediatric or specialized units to ensure refined post-transplant monitoring.</p> <p><strong>Patient Consensus:</strong> Expect recovery to be highly individualized based on your daily blood counts. While the initial stay is a few weeks, plan for 6 to 12 months of monitoring nearby.</p>"},{"q":"Why do many patients choose Spain for their allogeneic bone marrow transplant?","a":"<p>Patients choose Spain for allogeneic bone marrow transplants because it maintains the world second largest cord blood registry and a top-tier European donor network. High success rates reaching 90 percent, Joint Commission International accredited facilities, and specialists certified by the European Society for Blood and Marrow Transplantation ensure safety.</p> <ul> <li><strong>Success rates:</strong> Clinics report 70 to 90 percent success depending on the patient clinical profile.</li> <li><strong>Clinical expertise:</strong> Spanish hematologists like Dr. Francesc Cobo Valien possess over 25 years of experience.</li> <li><strong>Accreditation standards:</strong> Leading centers like Clinica Universidad de Navarra was the first JCI-accredited in Spain.</li> <li><strong>Affordable care:</strong> Procedures cost _op_177_price_from_ to _op_177_price_to_, saving up to _price_percent_discount_% vs US costs.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Spain offers a unique advantage for pediatric cases. SJD Barcelona Children's Hospital is among Europe top three for pediatric oncology. Some clinics like Quironsalud Madrid even offer opportunities for patients to participate in clinical trials. This access to experimental therapies provides additional options when standard treatments are exhausted.</p> <p><strong>Patient Consensus:</strong> Patients value confirming outcomes directly with clinics to ensure board-certified hematologists perform the transplantation. Reliability and high success rates are the primary focus for those choosing Spain over other regions.</p>"}],"h2":[{"text":"Як це працює","kind":"content"},{"text":"Яка вартість алогенної трансплантації кісткового мозку від родинного донора в Іспанії?","kind":"content"},{"text":"Пропозиції з алогенної трансплантації кісткового мозку від родинного донора в Іспанії — листопад 2026","kind":"content"},{"text":"Дізнайтеся про найкращі клініки з алогенної трансплантації кісткового мозку від родинного донора у Іспанії: 5 перевірених клінік та ціни","kind":"content"},{"text":"Огляд процедури Трансплантація кісткового мозку алогенна від спорідненого донора в Іспанії","kind":"content"},{"text":"Отримайте медичну консультацію щодо алогенної трансплантації кісткового мозку від родинного донора в Іспанії: Обирайте серед найкращих фахівців у галузі","kind":"content"},{"text":"Відеоісторії пацієнтів Bookimed","kind":"content"},{"text":"Відгуки про Bookimed: дізнайтеся про реальний досвід пацієнтів","kind":"content"},{"text":"Поділитися цим контентом","kind":"content"},{"text":"Ключові факти про алогенну трансплантацію кісткового мозку від родинного донора","kind":"content"},{"text":"FAQ з алогенної трансплантації кісткового мозку від родинного донора в Іспанії","kind":"content"},{"text":"Отримати безкоштовну консультацію","kind":"content"}]},"placeholders":{"price_from":"{{price_from}}","clinics_count":"{{clinics_count}}","cities_count":"{{cities_count}}","savings_pct":"{{savings_pct}}","data_date":"{{data_date}}"},"legal":{"restricted_markets":{"status":"missing","reason":"not_collected"}},"conflicts":[]}